Astrana Health (ASTH) Revenue (2010 - 2026)

Astrana Health (ASTH) has 17 years of Revenue data on file, last reported at $965.1 million in Q1 2026.

• Quarterly Revenue rose 55.56% year-over-year to $965.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 billion (up 56.69% YoY) and the FY2025 annual result came in at $3.2 billion, up 56.39% from the prior year.
• Revenue improved to $965.1 million in Q1 2026 per ASTH's latest filing, from $950.5 million in the prior quarter.
• The five-year high for Revenue was $965.1 million in Q1 2026, with the low at $263.3 million in Q1 2022.
• Average Revenue over 5 years is $512.5 million, with a median of $404.4 million recorded in 2024.
• Year-over-year, Revenue advanced 9.83% in 2023 and soared 99.71% in 2025.
• Astrana Health's Revenue stood at $294.2 million in 2022, then rose by 20.0% to $353.0 million in 2023, then surged by 88.43% to $665.2 million in 2024, then soared by 42.89% to $950.5 million in 2025, then increased by 1.53% to $965.1 million in 2026.
• Business Quant data shows ASTH's Revenue at $965.1 million in Q1 2026, $950.5 million in Q4 2025, and $956.0 million in Q3 2025.